The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006
Open accessAbstract
BACKGROUND: Venous thromboembolism (VTE) frequently complicates cancer. Data on tumour-specific VTE predictors are limited, but may inform strategies to prevent thrombosis. METHODS: We computed incidence rates (IRs) with 95% confidence intervals (CIs) for VTE hospitalisation in a cohort of cancer patients (n=57,591) and in a comparison general-population cohort (n=287,476) in Denmark. The subjects entered the study in 1997-2005, and the follow-up continued through 2006. Using Cox proportional-hazards regression, we estimated relative risks (RRs) for VTE predictors, while adjusting for comorbidity. RESULTS: Throughout the follow-up, VTE IR was higher among the cancer patients (IR=8.0, 95% CI=7.6-8.5) than the general population (IR=4.7, 95% CI=4.3-5.1), particularly in the first year after cancer diagnosis (IR=15.0, 95% CI=13.8-16.2, vs IR=8.6, 95% CI=7.6-9.9). Incidence rates of VTE were highest in patients with pancreas (IR=40.9, 95% CI=29.5-56.7), brain (IR=17.7, 95% CI=11.3-27.8) or liver (IR=20.4, 95% CI=9.2-45.3) tumours, multiple myeloma (IR=22.6, 95% CI=15.4-33.2) and among patients with advanced-stage cancers (IR=27.7, 95% CI=24.0-32.0) or those who received chemotherapy or no/symptomatic treatment. The adjusted RR (aRR) for VTE was highest among patients with pancreas (aRR=16.3, 95% CI=8.1-32.6) or brain cancer (aRR=19.8 95% CI=7.1-55.2), multiple myeloma (aRR=46.1, 95% CI=13.1-162.0) and among patients receiving chemotherapy, either alone (aRR=18.5, 95% CI=11.9-28.7) or in combination treatments (aRR=16.2, 95% CI=12.0-21.7). CONCLUSIONS: Risk of VTE is higher among cancer patients than in the general population. Predictors of VTE include recency of cancer diagnosis, cancer site, stage and the type of cancer-directed treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Danish Civil Registration System
Pedersen, C. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,632
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
Singhal, S., Mehta, J., Desikan, R., Ayers, D., Roberson, P., Eddlemon, P., Munshi, N., Anaissie, E., Wilson, C., Dhodapkar, M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412102 · Cited by 2,575 · cited 1×
“New treatments for myeloma emerged during the period of our analysis, including the anti-angiogenic agents thalidomide and lenalidomide (Hales, 1999; Singhal et al, 1999).”
BackgroundThe Danish National Hospital Register. A valuable source of data for modern health sciences.
Andersen, T. F., Madsen, M., Jørgensen, J. O. L., Mellemkjoer, L., & Olsen, J. H. (1999) · PubMed · Cited by 2,026
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, J. W. (2005) · JAMA · doi:10.1001/jama.293.6.715 · Cited by 1,949
The Danish Civil Registration System. A cohort of eight million persons.
Pedersen, C. B., Gøtzsche, H., Møller, J. O., & Mortensen, P. B. (2006) · PubMed · Cited by 1,617
Incidence of Venous Thromboembolism and Its Effect on Survival Among Patients With Common Cancers
Chew, H. K., Wun, T., Harvey, D. J., Zhou, H., & White, R. H. R. (2006) · Archives of Internal Medicine · doi:10.1001/.458 · Cited by 1,321
Levitan, N., Dowlati, A., Remick, S. C., Tahsildar, H. I., Sivinski, L. D., Beyth, R., & Rimm, A. A. (1999) · Medicine · doi:10.1097/00005792-199909000-00001 · Cited by 891
Detection of Deep-Vein Thrombosis by Real-Time B-Mode Ultrasonography
Lensing, A. W. A., Prandoni, P., Brandjes, D., Huisman, P. M., Vigo, M., Tomasella, G., Krekt, J., ten Cate, J. W., Huisman, M. V., & Büller, H. R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902093200602 · Cited by 875
When an Entire Country Is a Cohort
Frank, L. (2000) · Science · doi:10.1126/science.287.5462.2398 · Cited by 864
The Danish Cancer Registry--history, content, quality and use.
Storm, H. H., Michelsen, E. V., Clemmensen, I. H., & Pihl, J. (1997) · PubMed · Cited by 790
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., & Lyman, G. H. (2007) · Cancer · doi:10.1002/cncr.23062 · Cited by 781
BLOM, J. W., VANDERSCHOOT, J. P. M., OOSTINDIËR, M. J., OSANTO, S., VAN DER MEER, F. J. M., & ROSENDAAL, F. R. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01804.x · Cited by 692
Trousseau, A. (1865) · Medical Entomology and Zoology · Cited by 635
The Risk of a Diagnosis of Cancer after Primary Deep Venous Thrombosis or Pulmonary Embolism
Sørensen, H. T., Mellemkjær, L., Steffensen, F. H., Olsen, J. H., & Nielsen, G. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804233381701 · Cited by 620
Self-citationIncidence of Venous Thromboembolism in Patients Hospitalized with Cancer
Stein, P. D., Beemath, A., Meyers, F. A., Skaf, E., Sanchez, J., & Olson, R. E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.058 · Cited by 566
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Gomez, M. L., Gomez‐Raposo, C., & Lobo Samper, F. (2008) · Cancer · doi:10.1002/cncr.23524 · Cited by 549
Cancer and venous thromboembolism
Prandoni, P., Falanga, A., & Piccioli, A. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70207-2 · Cited by 540
Venous thromboembolism and cancer
Baron, J. A., Gridley, G., Weiderpass, E., Nyren, O., & Linet, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10018-6 · Cited by 513
Self-citationZwicker, J. I., Liebman, H. A., Neuberg, D., Lacroix, R., Bauer, K. A., Furie, B. C., & Furie, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0371 · Cited by 479
Clinique médicale de l'Hôtel-Dieu de Paris
Trousseau, A. (1877) · Harvard Library (Harvard University) · Cited by 410
Huerta, C. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.935 · Cited by 408
Glynn, R. J., & Rosner, B. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi309 · Cited by 380
Incidence of Venous Thromboembolism in Hospitalized Patients vs Community Residents
Heit, J. A., Melton, L. J., Lohse, C. M., Petterson, T. M., Silverstein, M. D., Mohr, D. N., & Michael O’Fallon, W. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.11.1102 · Cited by 373
Lenalidomide and Venous Thrombosis in Multiple Myeloma
(2006) · New England Journal of Medicine · doi:10.1056/nejmc053530 · Cited by 232
Severinsen, M. T., Kristensen, S. R., Overvad, K., Dethlefsen, C., Tjønneland, A., & Johnsen, S. P. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.03.018 · Cited by 206
Epidemiology of Thrombosis in Cancer
Rickles, F. R., & Levine, M. N. (2001) · Acta Haematologica · doi:10.1159/000046583 · Cited by 200
Venous Thromboembolism in the Hematologic Malignancies
Falanga, A., & Marchetti, M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8197 · Cited by 192
Hernandez, R. K., Sørensen, H. T., Pedersen, L., Jacobsen, J., & Lash, T. L. (2009) · Cancer · doi:10.1002/cncr.24508 · Cited by 185
Self-citationVenous thromboembolism in ovarian cancer
Rodriguez, A. O., Wun, T., Chew, H. K., Zhou, H., Harvey, D. J., & White, R. H. R. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.02.024 · Cited by 169
Completeness of Cancer Registration in Denmark 1943–1966 and Efficacy of Record Linkage Procedures
Storm, H. H. (1988) · International Journal of Epidemiology · doi:10.1093/ije/17.1.44 · Cited by 142
Arcelus, J. I., Caprini, J. A., Monréal, M., Suárez, C., & González-Fajardo, J. A. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00789-4 · Cited by 133
Trousseau’s syndrome – what is the evidence?
Bergqvist, D., Wåhlander, K., Eriksson, H., Sternby, N. H., & Ögren, M. (2006) · Thrombosis and Haemostasis · doi:10.1160/th05-10-0694 · Cited by 99
Thalidomide on the comeback trail
Hales, B. F. (1999) · Nature Medicine · doi:10.1038/8371 · Cited by 70
White, R. H. R., Chew, H. K., & Wun, T. (2007) · Thrombosis Research · doi:10.1016/s0049-3848(07)70128-7 · Cited by 52
Cited by
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128
Lyman, G. H., Bohlke, K., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7351 · Cited by 1,371
Epidemiology of cancer-associated venous thrombosis
Timp, J. F., Braekkan, S. K., Versteeg, H. H., & Cannegieter, S. C. (2013) · Blood · doi:10.1182/blood-2013-04-460121 · Cited by 1,205
Venous thromboembolism in cancer patients: a population-based cohort study
Mulder, F. I., Horváth-Puhó, E., van Es, N., van Laarhoven, H. W. M., Pedersen, L., Moik, F., Ay, C., Büller, H. R., & Sørensen, H. T. (2021) · Blood · doi:10.1182/blood.2020007338 · Cited by 723
Self-citationLyman, G. H., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., Gates, L. E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.1118 · Cited by 713
Metadata
- Authors
- Cronin-Fenton, D. P., Søndergaard, F., Pedersen, L. A., Fryzek, J. P., Cetin, K., Acquavella, J., Baron, J. A., & Sørensen, H. T.
- Venue
- British Journal of Cancer
- Published
- 2010-09
- Volume
- 103
- Issue
- 7
- Pages
- 947-953
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2056208055
- Cited by
- 372
- References
- 34
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.